StockGlow

Regeneron Pharmaceuticals, Inc. (REGN)

$651.91+0.00%
Market signal
62
Leaning Bullish
BearishBullish

The outlook

Regeneron trades at $651.91 with analyst consensus strongly favoring a buy rating; the average price target sits about 26% above the current level. The stock is positioned in the lower half of its 52-week range and shows mixed momentum against moving averages, though the overall market signal leans bullish. At a trailing P/E of 15.9, valuation appears moderate relative to the analyst outlook.

What's behind the signal

Analyst consensusBuy — 1.8 avg of 26 analysts
Price trendMixed vs its moving averages
52-week range40% of the way from its 52-week low to high
Price targetAvg target +26% vs current price
Market cap
$68.35B
52-wk high
$821.11
52-wk low
$541.00
50-day avg
$641.68
200-day avg
$705.78
Trailing P/E
15.9

The “market signal” is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works